These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37256914)

  • 21. Racial Differences in Risk Factors for Kidney Stone Formation.
    Zisman AL; Coe FL; Cohen AJ; Riedinger CB; Worcester EM
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1166-1173. PubMed ID: 32561654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical risk factors for stone formation in a Scottish paediatric hospital population.
    MacDougall L; Taheri S; Crofton P
    Ann Clin Biochem; 2010 Mar; 47(Pt 2):125-30. PubMed ID: 20144971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of metabolic parameters between pure-uric acid and mixed-uric acid kidney stone formers.
    Ricapito A; Gupta K; Zipkin J; Yim S; Connors C; Khargi R; Yaghoubian AJ; Khusid JA; Atallah WM; Gupta M
    World J Urol; 2024 Mar; 42(1):138. PubMed ID: 38478092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronobiology of urinary citrate excretion amongst stone-formers and healthy males from north western India.
    Wangoo D; Thind SK; Gupta GS; Nath R
    Urol Res; 1991; 19(3):203-6. PubMed ID: 1887530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergence between stone composition and urine supersaturation: clinical and laboratory implications.
    Lingeman J; Kahnoski R; Mardis H; Goldfarb DS; Grasso M; Lacy S; Scheinman SJ; Asplin JR; Parks JH; Coe FL
    J Urol; 1999 Apr; 161(4):1077-81. PubMed ID: 10081841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a high-citrate beverage on urine chemistry in patients with calcium kidney stones.
    Goldfarb DS; Modersitzki F; Asplin JR; Nazzal L
    Urolithiasis; 2023 Jul; 51(1):96. PubMed ID: 37479949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of urinary sex steroid hormones with urinary calcium, oxalate and citrate excretion in kidney stone formers.
    Fuster DG; Morard GA; Schneider L; Mattmann C; Lüthi D; Vogt B; Dhayat NA
    Nephrol Dial Transplant; 2022 Jan; 37(2):335-348. PubMed ID: 33295624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A; Hochreiter W; Jaeger P; Hess B
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations.
    Cheungpasitporn W; Erickson SB; Rule AD; Enders F; Lieske JC
    J Urol; 2016 May; 195(5):1476-1481. PubMed ID: 26598423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noncitrus alkaline fruit: a dietary alternative for the treatment of hypocitraturic stone formers.
    Baia Lda C; Baxmann AC; Moreira SR; Holmes RP; Heilberg IP
    J Endourol; 2012 Sep; 26(9):1221-6. PubMed ID: 22500592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.